Get started
Author

Lev S. Butaev

Observed names: L. S. Butaev, L.S. Butaev, Lev Butaev, Бутаев Л.С., Бутаев Лев Сергеевич, Л С Бутаев
Observed institutions: North-Eastern Federal University, King Hussein Cancer Center, Rigshospitalet, Botkin Hospital, City Clinical Hospital, State Scientific Center of the Russian Federation - Federal Medical Biophysical Center named after A.I. Burnazyan, Jawaharlal Institute of Post Graduate Medical Education and Research, Federal Medical-Biological Agency, Alexandria University
ORCID: 0000-0002-1060-3804
Observed ORCID: 0000-0002-1060-3804
OpenAlex ID: A5002077604
Clinical Outcomes in Patients With COVID-19 and Hematologic Disease
2023 · Olga A. Aleshina, Kristina Zakurdaeva, et al. · Clinical Lymphoma Myeloma & Leukemia · 9
PDF
COVID-19 and hematologic diseases: Risk factors and long-term follow-up of CHRONOS19 Registry.
2021 · Kristina Zakurdaeva, Olga A. Gavrilina, et al. · Journal of Clinical Oncology · 4
Outcomes in Patients with Hematologic Disease and COVID-19 in Russia: Interim Analysis of CHRONOS19 Registry
2020 · Olga A. Gavrilina, Kristina Zakurdaeva, et al. · Blood · 4
PDF
Ibrutinib Monotherapy in Patients with Relapsed/Refractory Mantle Cell Lymphoma in Community Clinical Practice Outside of Clinical Trials
2019 · Vladimir I. Vorobyev, Vera A. Zherebtsova, et al. · Blood · 2
Real-world outcomes of glofitamab therapy in CAR-T naive patients with relapsed/refractory B-cell lymphoma
2025 · Liudmila Fedorova, Nataliia Mikhailova, et al. · Blood · 1
PDF
Abatacept/Tacrolimus or Abatacept/Tacrolimus/Post-Transplant Cyclophosphamide Are Safe and Highly Effective in Preventing Graft-Versus-Host Disease in Matched or Mismatched Donor Peripheral Blood Stem Cell Transplantation
2022 · Vladimir I. Vorobyev, Anton Yu. Subora, et al. · Blood · 1
Final Results of CHRONOS19 Observational Study in Patients with Hematologic Disease and COVID-19 in Russia
2021 · Olga A. Gavrilina, Kristina A. Zakurdaeva, et al. · Blood · 1
PDF
Real-world outcomes of glofitamab therapy in CAR-T–naïve patients with relapsed/refractory large B-cell lymphoma
2026 · Liudmila Fedorova, Natalia Mikhailova, et al. · Blood Immunology & Cellular Therapy
Is Venetoclax Effective in Combination with Standard Therapy for Relapses of Diffuse Large B-Cell Lymphoma?
2026 · L.S. Butaev, V.A. Zherebtsova, et al. · A I Burnasyan Federal Medical Biophysical Center Clinical Bulletin
Efficacy and Safety of Glofitamab Therapy in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A United Russian Experience Based on the Compassionate Use Program
2026 · Liudmila Valerevna Fedorova, N. B. Mikhailova, et al. · Clinical oncohematology
PDF
Aggregated experience with the use of mosunetuzumab for the treatment of relapsed / refractory follicular lymphoma in Russia: four centers experience
2025 · Lev S. Butaev, M. A. Sannikova, et al. · Oncohematology
PDF
Use of Venetoclax in the Therapy of Patients with Relapsed or Refractory B-Cell (Experience of the s.p. Botkin Moscow Multidisciplinary Scientific and Clinical Center)
2024 · L.S. Butaev, Yu.A. Oleynik, et al. · A I Burnasyan Federal Medical Biophysical Center Clinical Bulletin
PDF
1590P Treatment outcomes and antibody immunity to SARS-CoV-2 in patients with hematological malignancies
2021 · K. Zakurdaeva, O.A. Gavrilina, et al. · Annals of Oncology
PDF
ABCL-274: Outcomes in Patients with Lymphoproliferative Diseases and COVID-19: Results of a Subgroup Analysis of the CHRONOS19 Registry
2021 · Olga Gavrilina, Kristina Zakurdaeva, et al. · Clinical Lymphoma Myeloma & Leukemia
PDF
Poster: ABCL-274: Outcomes in Patients with Lymphoproliferative Diseases and COVID-19: Results of a Subgroup Analysis of the CHRONOS19 Registry
2021 · Olga Gavrilina, Kristina Zakurdaeva, et al. · Clinical Lymphoma Myeloma & Leukemia
PDF
Five year experience in ibrutinib therapy for relapsed and refractory mantle cell lymphoma in real world Russian clinical practice
2021 · Vladimir I. Vorobyev, Eduard G. Gemdzhian, et al. · Terapevticheskii arkhiv
PDF
Фолликулярная лимфома с трансформацией в "triple-hit"-лимфому и делецией гена ТР53, резистентная к иммунохимиотерапии
2017 · Е С Нестерова, Т Н Обухова, et al. · Клиническая онкогематология. Фундаментальные исследования и клиническая практика
Family case of hereditary deficiency of antithrombin III
2016 · V. N. Yadrihinskaya, I. I. Mulina, et al. · European Journal of Biomedical and Life Sciences
Association of Chronic HBV Infection with Chronic Lymphoproliferative Disorders: A Review and Case Report
2016 · Snezhana Sleptsova, Vera Yadrichinskaya, et al. · International Journal of Biomedicine
PDF
Семейный случай наследственного дефицита антитромбина III
2016 · Ядрихинская Вера Николаевна, Мулина Инна Ивановна, et al. · European Journal of Biomedical and Life Sciences
Works count: 22
Citation count: 22
H-index: 3
I10-index:
Year
Topic
Type